$1.9
NuCana is a biotechnology business based in the US. NuCana shares (NCNA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.88 – a decrease of 2.59% over the previous week. NuCana employs 25 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy NuCana stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy NuCana stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NCNA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy NuCana stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
NuCana stock price (NASDAQ: NCNA)
Use our graph to track the performance of NCNA stocks over time.NuCana shares at a glance
Latest market close | $1.88 |
---|---|
52-week range | $1.86 - $17.50 |
50-day moving average | $3.85 |
200-day moving average | $5.06 |
Wall St. target price | $87.47 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-17.32 |
Is it a good time to buy NuCana stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NuCana price performance over time
Historical closes compared with the close of $1.88 from 2024-10-18
1 week (2024-10-14) | -2.59% |
---|---|
1 month (2024-09-20) | -41.52% |
3 months (2024-07-19) | -36.91% |
6 months (2024-04-19) | -50.20% |
1 year (2023-10-20) | 231.57% |
---|---|
2 years (2022-10-21) | 91.84% |
3 years (2021-10-21) | 2.57 |
5 years (2019-10-21) | 6.885 |
NuCana financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -68.43% |
Return on equity TTM | -180.77% |
Profit margin | 0% |
Book value | $1.69 |
Market Capitalization | $4.2 million |
TTM: trailing 12 months
NuCana share dividends
We're not expecting NuCana to pay a dividend over the next 12 months.
Have NuCana's shares ever split?
NuCana's shares were split on a 1:25 basis on 15 April 2024 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NuCana shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for NuCana shares which in turn could have impacted NuCana's share price.
NuCana share price volatility
Over the last 12 months, NuCana's shares have ranged in value from as little as $1.8607 up to $17.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NuCana's is 1.004. This would suggest that NuCana's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
NuCana overview
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase 1b/2 study in patients with metastatic colorectal cancer, Phase 2 clinical trial for the second-line treatment of patients with advanced colorectal cancer, and Phase 1b/2 modular clinical trial for patients with advanced solid tumors and lung cancer. It is also developing NUC-7738, a ProTide transformation of 3'-deoxyadenosine, which is in the Phase 2 part of a Phase 1/2 clinical trial for patients with advanced solid tumors. The company has an assignment, license, and collaboration agreement with Cardiff ProTides Ltd to discover, drug design, and in vitro screen purine and pyrimidine-based nucleosides as potential drug candidates. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017.
Frequently asked questions
What percentage of NuCana is owned by insiders or institutions?Currently 0.527% of NuCana shares are held by insiders and 10.647% by institutions. How many people work for NuCana?
Latest data suggests 25 work at NuCana. When does the fiscal year end for NuCana?
NuCana's fiscal year ends in December. Where is NuCana based?
NuCana's address is: 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT What is NuCana's ISIN number?
NuCana's international securities identification number is: US67022C1062 What is NuCana's CUSIP number?
NuCana's Committee on Uniform Securities Identification Procedures number is: 67022C106
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question